Brief: Medicenna Therapeutics Corp - Entered Into A Sales Agreement With Svb Leerink
30/12/2020 23:15
Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA THERAPEUTICS CORP - ENTERED INTO A SALES
AGREEMENT
WITH SVB LEERINK
* MEDICENNA THERAPEUTICS - PURSUANT TO AGREEMENT MAY SELL,
THROUGH
AT-THE-MARKET OFFERINGS, COMMON SHARES HAVING OFFERING PRICE OF
UP TO US$25 MILLION
Source text for Eikon: ID:nGNX9V1LPp
Further company coverage: MDNA.TO
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results